Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 5/20 | 0.38 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.38 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.36 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | RIPK3 | Q9Y572 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.34 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4976847 | 0.88 | TRAP1 (0.39) | AKR1B1PTGDR2SMN1; SMN2CYP1A2MAPT | |
| SCHEMBL4263802 | 0.82 | AKR1B1 (0.43) | AKR1B1AKR1B10AKR1A1PTGDR2 | |
| SCHEMBL5135636 | 0.78 | DAO (0.37) | AKR1B1AKR1B10AKR1A1NTRK1DAO | |
| SCHEMBL2486352 | 0.73 | PTGDR2 (0.62) | AKR1B1PTGDR2 | |
| SCHEMBL2484248 | 0.73 | PTGDR2 (0.64) | PTGDR2MAPTKMT2A | |
| SCHEMBL11096343 | 0.73 | AKR1B1 (0.52) | AKR1B1AKR1B10AKR1A1PTGDR2 | |
| SCHEMBL3957230 | 0.73 | ALDH1A1 (0.39) | AKR1B1AKR1A1PTGDR2CYP1A2MAPT | |
| SCHEMBL3950566 | 0.73 | AKR1B1 (0.42) | AKR1B1AKR1A1CYP1A2MAPTCYP2C19 | |
| SCHEMBL4979296 | 0.73 | AKR1B1 (0.41) | AKR1B1AKR1A1SMN1; SMN2CYP1A2MAPT | |
| SCHEMBL4266563 | 0.73 | HSP90AA1 (0.37) | AKR1B1PTGDR2DAOMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1984374-A1 | USE OF SPIRO Ý IMIDAZOLIDINE-4, 3'-INDOLE¨2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 | AstraZeneca AB (SE) | 2008-10-29 | — | — | EP | claimed |
| WO-2007091946-A1 | USE OF SPIRO [ IMIDAZOLIDINE-4, 3'-INDOLE] 2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 | ASTRAZENECA AB (SE) | 2007-08-16 | — | — | WO | claimed |